Literature DB >> 23150186

Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.

Sei Sasaki1, Motoko Chiga, Eriko Kikuchi, Tatemitsu Rai, Shinichi Uchida.   

Abstract

BACKGROUND: Familial form of nephrogenic diabetes insipidus (NDI) is a rare hereditary disease caused by arginine vasopressin type 2 receptor (AVPR2) or water channel aquaporin 2 (AQP2) gene mutations. It is speculated that 90% of NDI families carry disease-causing mutations in AVPR2 and 10% carry the mutations in AQP2; however, these percentages have not been supported by actual data. It is also unknown whether these percentages vary in different ethnic groups.
METHODS: Gene mutation analyses were performed for 78 Japanese NDI families. All exons and intron-exon boundaries of the AVPR2 and AQP2 genes were directly sequenced.
RESULTS: A total of 62 families (79%) carried disease-causing mutations in AVPR2, while nine families (12%) carried mutations in AQP2. We identified 22 novel putatively disease-causing mutations (19 in AVPR2 and 3 in AQP2). Regarding AVPR2, 52 disease-causing mutations were identified. Among them, missense mutations were most common (54%), followed by deletion mutations. In the 64 women who had monoallelic disease-causing AVPR2 mutations, 16 (25%) had NDI symptoms, including 4 complete NDI subjects. Regarding AQP2, 9 disease-causing mutations were identified in nine families. Two missense mutations and one deletion mutation showed a recessive inheritance, while one missense mutation and five small deletion mutations in the C-terminus of AQP2 showed a dominant inheritance.
CONCLUSIONS: Most Japanese NDI families carry disease-causing mutations in AVPR2 and 12% carry mutations in AQP2. A total of 22 novel putatively disease-causing mutations were identified. The relatively high occurrence of symptomatic carriers of AVPR2 mutations needs attention.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23150186     DOI: 10.1007/s10157-012-0726-z

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  32 in total

1.  Nephrogenic diabetes insipidus: update of genetic and clinical aspects.

Authors:  Sei Sasaki
Journal:  Nephrol Dial Transplant       Date:  2004-03-05       Impact factor: 5.992

Review 2.  Aquaporins in kidney pathophysiology.

Authors:  Yumi Noda; Eisei Sohara; Eriko Ohta; Sei Sasaki
Journal:  Nat Rev Nephrol       Date:  2010-01-26       Impact factor: 28.314

3.  Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus.

Authors:  Marie-Françoise Arthus; Michèle Lonergan; M Joyce Crumley; Anna K Naumova; Denis Morin; Luiz A DE Marco; Bernard S Kaplan; Gary L Robertson; Sei Sasaki; Kenneth Morgan; Daniel G Bichet; T Mary Fujiwara
Journal:  J Am Soc Nephrol       Date:  2000-06       Impact factor: 10.121

4.  X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.

Authors:  D G Bichet; M F Arthus; M Lonergan; G N Hendy; A J Paradis; T M Fujiwara; K Morgan; M C Gregory; W Rosenthal; A Didwania
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

5.  Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus.

Authors:  D G Bichet; M Birnbaumer; M Lonergan; M F Arthus; W Rosenthal; P Goodyer; H Nivet; S Benoit; P Giampietro; S Simonetti
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

Review 6.  Aquaporin 2: from its discovery to molecular structure and medical implications.

Authors:  Sei Sasaki
Journal:  Mol Aspects Med       Date:  2012-04-04

7.  Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine.

Authors:  P M Deen; M A Verdijk; N V Knoers; B Wieringa; L A Monnens; C H van Os; B A van Oost
Journal:  Science       Date:  1994-04-01       Impact factor: 47.728

Review 8.  Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation.

Authors:  A F van Lieburg; M A Verdijk; F Schoute; M J Ligtenberg; B A van Oost; F Waldhauser; M Dobner; L A Monnens; N V Knoers
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

9.  Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct.

Authors:  S Sasaki; K Fushimi; H Saito; F Saito; S Uchida; K Ishibashi; M Kuwahara; T Ikeuchi; K Inui; K Nakajima
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Immunological profile in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes.

Authors:  Masaya Fujimoto; Kohsuke Imai; Kenji Hirata; Reiichi Kashiwagi; Yoichi Morinishi; Katsuhiko Kitazawa; Sei Sasaki; Tadao Arinami; Shigeaki Nonoyama; Emiko Noguchi
Journal:  BMC Med Genet       Date:  2008-05-20       Impact factor: 2.103

View more
  20 in total

1.  Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.

Authors:  Alejandro García Castaño; Gustavo Pérez de Nanclares; Leire Madariaga; Mireia Aguirre; Sara Chocron; Alvaro Madrid; Francisco Javier Lafita Tejedor; Mercedes Gil Campos; Jaime Sánchez Del Pozo; Rafael Ruiz Cano; Mar Espino; Jose Maria Gomez Vida; Fernando Santos; Victor Manuel García Nieto; Reyner Loza; Luis Miguel Rodríguez; Emilia Hidalgo Barquero; Nikoleta Printza; Juan Antonio Camacho; Luis Castaño; Gema Ariceta
Journal:  Eur J Pediatr       Date:  2015-04-23       Impact factor: 3.183

2.  Novel autosomal recessive gene mutations in aquaporin-2 in two Chinese congenital nephrogenic diabetes insipidus pedigrees.

Authors:  Jing Cen; Min Nie; Lian Duan; Feng Gu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 3.  Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus.

Authors:  Detlef Bockenhauer; Daniel G Bichet
Journal:  Nat Rev Nephrol       Date:  2015-06-16       Impact factor: 28.314

4.  Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan.

Authors:  Masanobu Fujimoto; Shin-Ichi Okada; Yuki Kawashima; Rei Nishimura; Naoki Miyahara; Yasuo Kawaba; Keiichi Hanaki; Eiji Nanba; Yoshiaki Kondo; Takashi Igarashi; Susumu Kanzaki
Journal:  Yonago Acta Med       Date:  2014-07-30       Impact factor: 1.641

Review 5.  Lysosome dysfunction in the pathogenesis of kidney diseases.

Authors:  Kameswaran Surendran; Seasson P Vitiello; David A Pearce
Journal:  Pediatr Nephrol       Date:  2013-11-12       Impact factor: 3.714

6.  High-throughput chemical screening identifies AG-490 as a stimulator of aquaporin 2 membrane expression and urine concentration.

Authors:  Naohiro Nomura; Paula Nunes; Richard Bouley; Anil V Nair; Stanley Shaw; Erica Ueda; Nutthapoom Pathomthongtaweechai; Hua A Jenny Lu; Dennis Brown
Journal:  Am J Physiol Cell Physiol       Date:  2014-06-18       Impact factor: 4.249

7.  A NOVEL INTRAGENIC DELETION RELATED TO THE ARGININE VASOPRESSIN V2 RECEPTOR CAUSES NEPHROGENIC DIABETES INSIPIDUS.

Authors:  L Chen; T Gu; L Z Yang
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

8.  Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway.

Authors:  Fumiaki Ando; Eisei Sohara; Tetsuji Morimoto; Naofumi Yui; Naohiro Nomura; Eriko Kikuchi; Daiei Takahashi; Takayasu Mori; Alain Vandewalle; Tatemitsu Rai; Sei Sasaki; Yoshiaki Kondo; Shinichi Uchida
Journal:  Nat Commun       Date:  2016-11-28       Impact factor: 14.919

9.  A Rare Case of Congenital Diabetes Insipidus.

Authors:  Tanvi Rege; Srujana Polsani; Belinda Jim
Journal:  Front Med (Lausanne)       Date:  2015-07-07

10.  Novel AQP2 Mutations and Clinical Characteristics in Seven Chinese Families With Congenital Nephrogenic Diabetes Insipidus.

Authors:  Qian Li; Dan Tian; Jing Cen; Lian Duan; Weibo Xia
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.